Cargando…
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models
INTRODUCTION: Ex vivo experiments in extracorporeal membrane oxygenation (ECMO) circuits have identified octanol-water partition coefficient (logP, a marker of lipophilicity) and protein binding (PB) as key drug factors affecting pharmacokinetics (PK) during ECMO. Using ovine models, in this study w...
Autores principales: | Shekar, Kiran, Roberts, Jason A., Barnett, Adrian G., Diab, Sara, Wallis, Steven C., Fung, Yoke L., Fraser, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699331/ https://www.ncbi.nlm.nih.gov/pubmed/26667471 http://dx.doi.org/10.1186/s13054-015-1151-y |
Ejemplares similares
-
Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support
por: Passmore, Margaret R., et al.
Publicado: (2017) -
The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation
por: Shekar, Kiran, et al.
Publicado: (2013) -
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
por: Shekar, Kiran, et al.
Publicado: (2012) -
Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study
por: Shekar, Kiran, et al.
Publicado: (2015) -
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
por: Shekar, Kiran, et al.
Publicado: (2012)